A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors

This early-phase trial tests a new investigational drug called IAP0971 in people with advanced solid tumors or blood cancers that have not responded to standard treatments. The study first tests safety and finds the right dose, then expands to test effectiveness in specific cancer types. **You may be eligible if...** - You are between 18 and 75 years old - You have advanced solid tumor cancer or certain blood cancers confirmed by biopsy - Your cancer has not responded to standard treatments, or no standard treatment is available - You are in reasonably good overall health (able to care for yourself) **You may NOT be eligible if...** - You have active brain metastases (cancer spread to the brain) - You have had major surgery or radiotherapy recently without adequate recovery - You have serious heart, liver, or kidney problems Talk to your doctor to see if this trial is right for you.